Carlos A Arango-Franco1,2, Marcela Moncada-Vélez1, Claudia Patricia Beltrán3, Indira Berrío4,5, Cristian Mogollón6, Andrea Restrepo7, Mónica Trujillo7, Sara Daniela Osorio1,2, Lorena Castro1,2, Lina Vanessa Gómez7,8, Ana María Muñoz8, Verónica Molina7,8, Delsy Yurledy Del Río Cobaleda7, Ana Cristina Ruiz7, Carlos Garcés3,7, Juan Fernando Alzate9, Felipe Cabarcas9,10, Julio Cesar Orrego1, Jean-Laurent Casanova11,12,13,14,15, Jacinta Bustamante11,12,13,16, Anne Puel11,12,13, Andrés Augusto Arias17,18, José Luis Franco1. 1. Grupo de Inmunodeficiencias Primarias, Universidad de Antioquia UdeA, Calle 70 No. 52-21, Medellín, Colombia. 2. Escuela de Microbiología, Universidad de Antioquia UdeA, Calle 70 No. 52-21, Medellín, Colombia. 3. Departamento de Pediatría, Universidad de Antioquia UdeA, Calle 70 No. 52-21, Medellín, Colombia. 4. Medical and Experimental Mycology Group, Corporación para Investigaciones Biológicas (CIB), Medellín, Colombia. 5. Hospital General de Medellín "Luz Castro de Gutiérrez" ESE, Medellín, Colombia. 6. Infectología, Hospital Universitario Fernando Troconnis, Santa Marta, Colombia. 7. Hospital Pablo Tobón Uribe, Medellín, Colombia. 8. Servicio de Dermatología, Universidad Pontificia Bolivariana, Medellín, Colombia. 9. Centro Nacional de Secuenciación Genómica CNSG, Facultad de Medicina, Universidad de Antioquia UdeA, Calle 70 No 52-21, Medellín, Colombia. 10. Grupo SISTEMIC, Facultad de Ingeniería, Universidad de Antioquia UdeA , Calle 70 No 52-21, Medellín, Colombia. 11. Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM-U1163, Paris, EU, France. 12. Imagine Institute, Paris Descartes University, Paris, EU, France. 13. St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA. 14. Pediatric Hematology-Immunology Unit, Necker Hospital for Sick Children, AP-HP, Paris, France. 15. Howard Hughes Medical Institute, New York, NY, USA. 16. Center for the Study of Primary Immunodeficiencies, Necker Hospital for Sick Children, Paris, EU, France. 17. Grupo de Inmunodeficiencias Primarias, Universidad de Antioquia UdeA, Calle 70 No. 52-21, Medellín, Colombia. aaugusto.arias@udea.edu.co. 18. Escuela de Microbiología, Universidad de Antioquia UdeA, Calle 70 No. 52-21, Medellín, Colombia. aaugusto.arias@udea.edu.co.
Abstract
PURPOSE: CARD9 deficiency is an inborn error of immunity that predisposes otherwise healthy humans to mucocutaneous and invasive fungal infections, mostly caused by Candida, but also by dermatophytes, Aspergillus, and other fungi. Phaeohyphomycosis are an emerging group of fungal infections caused by dematiaceous fungi (phaeohyphomycetes) and are being increasingly identified in patients with CARD9 deficiency. The Corynespora genus belongs to phaeohyphomycetes and only one adult patient with CARD9 deficiency has been reported to suffer from invasive disease caused by C. cassiicola. We identified a Colombian child with an early-onset, deep, and destructive mucocutaneous infection due to C. cassiicola and we searched for mutations in CARD9. METHODS: We reviewed the medical records and immunological findings in the patient. Microbiologic tests and biopsies were performed. Whole-exome sequencing (WES) was made and Sanger sequencing was used to confirm the CARD9 mutations in the patient and her family. Finally, CARD9 protein expression was evaluated in peripheral blood mononuclear cells (PBMC) by western blotting. RESULTS: The patient was affected by a large, indurated, foul-smelling, and verrucous ulcerated lesion on the left side of the face with extensive necrosis and crusting, due to a C. cassiicola infectious disease. WES led to the identification of compound heterozygous mutations in the patient consisting of the previously reported p.Q289* nonsense (c.865C > T, exon 6) mutation, and a novel deletion (c.23_29del; p.Asp8Alafs10*) leading to a frameshift and a premature stop codon in exon 2. CARD9 protein expression was absent in peripheral blood mononuclear cells from the patient. CONCLUSION: We describe here compound heterozygous loss-of-expression mutations in CARD9 leading to severe deep and destructive mucocutaneous phaeohyphomycosis due to C. cassiicola in a Colombian child.
PURPOSE:CARD9 deficiency is an inborn error of immunity that predisposes otherwise healthy humans to mucocutaneous and invasive fungal infections, mostly caused by Candida, but also by dermatophytes, Aspergillus, and other fungi. Phaeohyphomycosis are an emerging group of fungal infections caused by dematiaceous fungi (phaeohyphomycetes) and are being increasingly identified in patients with CARD9 deficiency. The Corynespora genus belongs to phaeohyphomycetes and only one adult patient with CARD9 deficiency has been reported to suffer from invasive disease caused by C. cassiicola. We identified a Colombian child with an early-onset, deep, and destructive mucocutaneous infection due to C. cassiicola and we searched for mutations in CARD9. METHODS: We reviewed the medical records and immunological findings in the patient. Microbiologic tests and biopsies were performed. Whole-exome sequencing (WES) was made and Sanger sequencing was used to confirm the CARD9 mutations in the patient and her family. Finally, CARD9 protein expression was evaluated in peripheral blood mononuclear cells (PBMC) by western blotting. RESULTS: The patient was affected by a large, indurated, foul-smelling, and verrucous ulcerated lesion on the left side of the face with extensive necrosis and crusting, due to a C. cassiicolainfectious disease. WES led to the identification of compound heterozygous mutations in the patient consisting of the previously reported p.Q289* nonsense (c.865C > T, exon 6) mutation, and a novel deletion (c.23_29del; p.Asp8Alafs10*) leading to a frameshift and a premature stop codon in exon 2. CARD9 protein expression was absent in peripheral blood mononuclear cells from the patient. CONCLUSION: We describe here compound heterozygous loss-of-expression mutations in CARD9 leading to severe deep and destructive mucocutaneous phaeohyphomycosis due to C. cassiicola in a Colombian child.
Authors: Olaf Gross; Andreas Gewies; Katrin Finger; Martin Schäfer; Tim Sparwasser; Christian Peschel; Irmgard Förster; Jürgen Ruland Journal: Nature Date: 2006-07-12 Impact factor: 49.962
Authors: Anete S Grumach; Flavio de Queiroz-Telles; Mélanie Migaud; Fanny Lanternier; Nelson Rosario Filho; Sandra M U Palma; Rosemeire Navickas Constantino-Silva; Jean Laurent Casanova; Anne Puel Journal: J Clin Immunol Date: 2015-06-05 Impact factor: 8.317
Authors: Ana Van Den Rym; Prasad Taur; Rubén Martinez-Barricarte; Lazaro Lorenzo; Anne Puel; Pablo Gonzalez-Navarro; Ambreen Pandrowala; Vijaya Gowri; Amin Safa; Victor Toledano; Carolina Cubillos-Zapata; Eduardo López-Collazo; Maria Vela; Antonio Pérez-Martínez; Silvia Sánchez-Ramón; Maria J Recio; Jean-Laurent Casanova; Mukesh M Desai; Rebeca Perez de Diego Journal: J Clin Immunol Date: 2020-02-01 Impact factor: 8.317
Authors: Blanca Garcia-Solis; Ana Van Den Rym; Jareb J Pérez-Caraballo; Abdulwahab Al-Ayoubi; Anas M Alazami; Lazaro Lorenzo; Carolina Cubillos-Zapata; Eduardo López-Collazo; Antonio Pérez-Martínez; Luis M Allende; Janet Markle; Miguel Fernández-Arquero; Silvia Sánchez-Ramón; Maria J Recio; Jean-Laurent Casanova; Reem Mohammed; Rubén Martinez-Barricarte; Rebeca Pérez de Diego Journal: Front Immunol Date: 2021-11-12 Impact factor: 8.786